文献速递胃肠外科围术期管理与 ERAS

经口内镜下肌切开术治疗乙状结肠型贲门失弛缓症的长期结局:S1与S2亚型比较

Long-term outcome of peroral endoscopic myotomy for sigmoid-type achalasia: S1 vs S2 subtypes.
PubMed 文献 · Surg Endosc · 2025-11-07

该回顾性研究纳入78例接受POEM的乙状结肠型贲门失弛缓症患者,评估其安全性与疗效。技术成功率100%,2年、5年、10年临床失败率分别为1.3%、12.8%、42.5%;S1与S2亚型在手术参数、不良事件及临床失败率上无显著差异。

要点

  • POEM治疗乙状结肠型贲门失弛缓症技术成功率高,围术期主要不良事件少。
  • 2年和5年临床失败率较低,但10年失败率显著升高,需关注长期疗效耐久性。
  • S1与S2亚型在手术参数、不良事件及临床失败率上无显著差异。

核心结论

  • POEM治疗乙状结肠型贲门失弛缓症在2年和5年随访时安全有效,但10年临床失败率显著,长期耐久性仍存担忧。
  • S1与S2亚型的临床结局相似。

研究设计与样本

  • 回顾性纳入78例接受POEM治疗的乙状结肠型贲门失弛缓症患者。
  • 主要结局为临床成功,定义为术后Eckardt评分≤3分;次要结局为围术期不良事件和手术相关参数。

主要发现

  • 术前平均Eckardt评分为7.3±2.0,52例(66.7%)病程≥10年;S1型62例,S2型16例。
  • 技术成功率100%,平均手术时间80.4±40.5分钟,平均住院时间2.9±1.7天。
  • 术中黏膜损伤18例(23.1%),包括I型14例(17.9%)和II型4例(5.1%),均予夹闭且未引起并发症。
  • CT显示气体相关不良事件7例(9.0%)、胸腔积液10例(12.8%)、肺炎10例(12.8%)、局灶性肺不张6例(7.7%),均无症状且无需干预;主要不良事件1例,为术后胸腔积液需引流。
  • 2年、5年、10年临床失败率分别为1.3%、12.8%、42.5%;S1与S2亚型在手术参数、不良事件及临床失败率上无显著差异。

临床怎么用

  • POEM可作为乙状结肠型贲门失弛缓症的安全有效治疗选择,尤其适用于2年和5年疗效预期。
  • 术后10年临床失败率较高,需对患者进行长期随访监测。
  • S1与S2亚型均可采用POEM治疗,无需因亚型差异改变策略。

局限性

  • 回顾性研究设计。
  • 样本量较小(78例),尤其S2型仅16例。
  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The sigmoid-type achalasia is an advanced stage of achalasia characterized by severe dilatation, tortuous angulation, and rotation of the esophageal body. Our aim is to explore the safety, and efficacy of peroral endoscopic myotomy (POEM) for sigmoid-type achalasia. MATERIALS AND METHODS: A total of 78 patients who underwent POEM for sigmoid-type achalasia were retrospectively included. The primary outcome was clinical success, defined as a postoperative Eckardt score ≤ 3 points. Secondary outcomes were perioperative adverse events (AEs), and procedure-related parameters. RESULTS: The mean pre-POEM Eckardt score was 7.3 ± 2.0 and 52 patients (66.7%) had a disease duration of ≥ 10 years. S1 type was found in 62 patients and S2 type in 16 patients. The technical success rate was 100%. The mean procedure duration was 80.4 ± 40.5 min and the mean hospital stay was 2.9 ± 1.7 days. Intraoperative mucosal injury occurred in 18 (23.1%) patients, including 14 (17.9%) type I and 4 (5.1%) type II. All mucosal injury were clipped and did not induce any complications. CT revealed gas-related AEs in 7 cases (9.0%), pleural effusions in 10 cases (12.8%), pneumonitis in 10 cases (12.8%), and focal atelectasis in 6 cases (7.7%). The above AEs only appear on CT scans, are asymptomatic, and do not require intervention. Major AEs were found in 1 patient. This patient developed a postoperative pleural effusion that required drainage. The clinical failure rate at 2-year, 5-year, and 10-year follow-up visits were 1.3%, 12.8%, and 42.5%, respectively. There were no significant differences between type S1 and S2 achalasia in terms of procedure-related parameters, AEs and clinical failure rates. CONCLUSIONS: POEM is a safe and effective procedure for sigmoid-type achalasia at the 2-year and 5-year follow-up visits. However, a significant rate of clinical failure was observed at 10 years, highlighting that long-term durability remains a concern in managing this advanced disease stage. Clinical outcomes were similar for both S1 and S2 types of achalasia.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Xu P, Liu Z, Tan Y, et al. Long-term outcome of peroral endoscopic myotomy for sigmoid-type achalasia: S1 vs S2 subtypes. Surg Endosc. 2025. PMID: 41201588. doi:10.1007/s00464-025-12370-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。